Paperless Validation Trends in Pharma, Biotech, and Medical Devices

Paperless Validation Trends in Pharma, Biotech, and Medical Devices

When paperless validation systems were introduced into the industry, they provided standard document management and electronic execution capabilities. These basic functions enabled companies to electronically review, approve and execute validation lifecycle documentation, including protocols. Absent from these early systems were full automation, workflows, and integration with change management. Over the past ten years, digitized validation technology has matured beyond just document management and electronic execution. New functionalities now include:

  • Templates for various document deliverables to help enforce compliance
  • Instant, digital workflows for review and approval of various processes and documents
  • Risk Models to perform system-level and requirement-level risk assessment
  • Projects to manage validation projects and enforce dependencies
  • Forms to capture and manage data in a natively digital manner
  • Decision Trees to enforce consistencies in Risk Assessment, Framework
  • Definition and Protocol Development
  • Schedules to manage periodic re-validation and re-verification
  • Change workflows to manage system-level and requirement-level changes

Although “paperless” technology has been available for over ten years, the industry has been slow to adopt and take advantage of it. However, the in-person dynamic of the entire discipline is changing, and the industry is now keenly looking at digitized validation systems to overcome the inefficiencies of paper-based processes and facilitate collaboration between distributed and remote teams. On-site audits and inspections have become harder. Digital, virtual collaboration is a necessity.

In the next ten years, technology will further integrate with MES, process control, LIMS, and other electronic systems by leveraging cutting-edge technologies such as IIoT, AI, and augmented reality to fully automate the entire validation lifecycle process.

?

Augmented Reality in Digital Validation

The Validation Lifecycle Management System (VLMS) from ValGenesis already supports Augmented Reality (AR) for remote and hands-free validation.

Remote and hands-free validation will improve efficiency, data integrity governance, and compliance in the corporate validation process. It will also simplify the task of validation by putting it into the context of the work itself.

For example, during validation and qualification in cleanrooms and aseptic manufacturing facilities, engineers can instantly access and view work instructions, schematics, and protocol test steps with a simple voice command to the wearable AR device. Protocol details can be captured simply by dictating results. Objective evidence, such as photos and videos, can be added with intuitive voice commands. These results will be securely recorded in real-time as part of a validation process fully compliant with FDA 21 CFR Part 11 and Annex 11 requirements.

In addition, the on-demand remote assistance functionality allows validation Subject Matter Experts (SMEs) to quickly pull in a colleague or supervisor when their expertise is required. This includes on-demand video calls, real-time chats, and even the ability to share images that can consist of annotated markups from the expert.

?

Industrial Internet of Things (IIoT)

Industrial Internet of Things (IIoT) technology is increasingly critical in pharmaceutical and biotech manufacturing, where sub-optimal environmental conditions often lead to noncompliance. Pharma IoT establishes transparency in drug manufacturing, storage, and logistics by enabling multiple sensors to monitor real-time environmental indicators like temperature, humidity, radiation, and light. Digitizing manufacturing facilities such as cleanroom environments can automate data collection through monitoring devices that provide empirical evidence for validation processes and alerts for out-of-specification limits.

?

Agile Methodology in Life Sciences

Agile Methodology in the life sciences industry is moving center stage, replacing the traditional Waterfall Method. Agile is proving cost-effective while staying within the regulatory framework.

Agile Methodology focuses on agility, continuous development, and product quality integrity. Its inherent flexibility and customer-centricity speed product delivery, promote teamwork and accountability, and encourage collaboration between business and IT. More importantly, it enables requirement changes at any time!

The technology driving life sciences is constantly changing. Continual improvement is necessary to be competitive in our highly regulated industry! We’ve evolved to an experience economy where the need to reduce errors and costs while increasing attention and productivity puts tremendous pressure on companies. Technological solutions that ease this tension are essential.


The opinions, information and conclusions contained within this blog should not be construed as conclusive fact, ValGenesis offering advice, nor as an indication of future results.

Bhadra Rao Chitturi

IT & QC Consultant

3 个月

I agree!

要查看或添加评论,请登录

社区洞察

其他会员也浏览了